A retrospective cohort study on the efficacy and safety for combination therapy of immunotherapy, targeted agent, and chemotherapy versus immunochemotherapy or chemotherapy alone in the first-line treatment of advanced biliary tract carcinoma.

Jie Zeng,Jie Ma,Zhiming Zeng,Lihua Yang,Yanfeng Jiang,Ning Mo,Fuchao Ma,Cuizhen Liu,Rong Li, Jing Tang,Shanyu Qin,Haixing Jiang

Journal of gastrointestinal oncology（2023）

引用 0|浏览2

暂无评分

摘要

Anti-PD-1/PD-L1 immunotherapy in combination with anlotinib and gemcitabine showed promising efficacy and an acceptable safety profile for the BTC patients included in this study.

查看译文

关键词

Biliary tract carcinoma (BTC), chemotherapy, targeted therapy, immunotherapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要